So far, great efforts have been made to understand the demands of extremely premature neonates (EPNs´; born before the 28 th week of gestation) on postnatal care, including optimal oxygen saturation, that will allow them to survive without disability. A major yet unresolved problem is to find an "optimal range" of their oxygen saturation and to maintain it without drops or increases, i.e., without hypoxia or hyperoxia. The individual sections of this paper deal with the changes of SpO2 (an estimate of SaO2 measured by pulse oximetry) that occur before, during, and after premature labor, postnatal factors affecting SpO2, and especially how to find an acceptable compromise in choosing the most effective and minimally harmful range of SpO2 for EPNs' with the careful FiO2 adjustment and continually monitored SpO2. At present, the two SpO2 ranges, narrow (90-94%) vs. wider (88-94%), are most discussed.
Introduction
Extremely prematurity remains a global health problem. Despite an increasing amount of knowledge in neonatology and technological advances during last two decades, the extremely premature neonates (EPNs') (below 28 weeks' gestation) remain at high risk for death and disability with 30-50% mortality and, in survivors, at least 20-50% of morbidity (Glass et al. 2015) .
The conclusions of five large clinical trials from 2010-2016, comparing the effectiveness and safety of the higher (91-95%) vs. lower (85-89%) oxygen saturation range in EPNs', supported the higher oxygen saturation range due to lower institutional mortality despite an increased incidence of retinopathy of prematurity (ROP). However, the question of what is the optimal oxygen saturation for EPNs' remains still open. Discussions on this topic are continuing with periodically changing intensity without a final consensus being reached.
This review provides a summary of the current findings and opinions on how to provide an effective and safe oxygen treatment in the EPNs'.
Brief history of oxygen therapy in premature infants
In 1940-50, the liberal administration of oxygen to the preterm newborn infants caused literally an epidemic of retrolental fibroplasia (RLF) (Terry 1942 , Campbell 1951 , Cross 1951 , today called as retinopathy of prematurity (ROP). The restriction in oxygen administration in the 1960-70 has brought the reduction of incidence of retinal damage, but mortality due to hypoxia and the number of premature infants affected by hypoxia have risen again.
Searching for the optimal markers of the oxygenation and their values in preterm neonates, indicating the risk of hypoxemia or hyperoxemia continues with the same intensity to this day.
Pulse oximetry -it is the most commonly used method of measuring oxygen saturation (SpO2). Pulse oximeter reading is a transcutaneous estimate of SaO2. This technology is based on the principle that oxyhemoglobin (HbO2) and deoxyhemoglobin (Hb) differently absorb red and near-red light. A microprocessor in pulse oximeters has an algorithm that uses ratio to determine the percentage of Hb bound to oxygen (SpO2) (Chan at al. 2013) . HbF has fairly similar absorbance pattern compared to HbA leading to similar functional SpO2 measurements (Arikan et al. 1998) . The standard manufacturers' claim of accuracy of detection of SaO2 using the SpO2 measured by pulse oximeters is ± 2-3% over the range of 70-100% SpO2 (Milner and Mathews 2012). All together this can mean up to 6%, which may be a problem when measuring too narrow range of SpO2 (Nitzan et al. 2014 , Lakshminrusimha et al. 2015 . The pulse oximetry and SpO2 measurement. The most commonly used non-invasive method is undoubtedly pulse oximetry measuring oxygen saturation of the fetus or neonate (FpO2/SpO2). This technology is based on a different absorption of infrared light by oxygenated or deoxygenated hemoglobin (HbO2, Hb). The concentration of oxygen saturation measured by pulse oximetry (SpO2) and arterial blood sample (SaO2) differs by ± 2% (Nitzan et al. 2014) . The accuracy of measurement stated by the manufacturer is within ± 3%. All together this can mean up to 6%, which may be a problem when measuring too narrow range of SpO2 (Nitzan et al. 2014 , Lakshminrusimha et al. 2015 . (HbO2) and deoxyhemoglobin (Hb). Depending on the manufactures, the device is able measure the ratio of HbO2 to total Hb as the tissue oxygenation index (TOI) or the regional cerebral oxygen saturation (rSO2) (da Costa et al. 2015) . Both, TOI and rSO2, can be used to calculate the fractional tissue oxygen extraction, which by taking varying arterial oxygen saturation measurement into account directly represents the balance between cerebral oxygen supply and cerebral oxygen consumption (Naulaers et al. 2007 ).
Invasive monitoring of PaO2 and

Oxygen saturation during fetal-neonatal transformation
In utero, the fetus develops at markedly lower PaO2 than after delivery. PaO2 in utero is about 3.4 -4.6 kPa (25-35 mmHg), while after delivery in term infant is between 10.6 -12.0 kPa (80 up to 90 mmHg) (Gao and Raj 2010). The placenta is the principal site of fetal blood gas exchange. Within the placenta, chorionic villi are wrapping with mixed arterial-venous maternal blood with a PO2 around 55 mmHg (7.3 kPa). The exchange of blood gases itself takes place during the flow of blood through the fetal intervillous space (Wu et al. 2016) .
Because HbF has a higher affinity to oxygen and its extraction from the intervillous space of placenta, and saturation with oxygen at the same PO2 is higher than that of HbA (Vento 
Target range of SpO2 in extremely premature neonates
Searching for target range of oxygen saturation defining normoxemia in premature infants has been taking place since the late 1940s. Methods assessing or estimating the oxygenation of EPNs', incl. pulse oximetry, described in the previous section, only partially extended our horizon of knowing the optimal target range of SaO2/SpO2 in these babies. together so that EPNs' were randomly assigned to the one of two preselected SpO2 ranges.
Their primary outcome was a composite of death or disability at 18-24 months' corrected age, the secondary outcome included occurrence of intraventricular hemorrhage (IVH), necrotizing enterocolitis (NEC), bronchopulmonary dysplasia (BPD), and retinopathy of prematurity (ROP). Death before discharge was a pre-specified secondary outcome only in the Boost II studies (Manja et al. 2015, Cummings and Lakshminrusimha 2017) . Data from over 5,000 tiniest neonates were collected and processed. Their analyses have shown that a higher target range SpO2 (91-95%) was associated with lower mortality at the age of 36 weeks after conception (i.e. before discharge), but also with increased occurrence of severe ROP. Later meta-analysis didn't confirm the increased incidence of ROP as significant (Cummings and Lakshminrusimha 2017) . On the other hand, the lower SpO2 range (85-89%) was found to be associated with an increased mortality at 36 post-conception weeks' and more frequent NEC although EPNs' with a liberal (higher) oxygen target had significantly lower mortality before discharge, the quality of evidence for this finding is low (Manja et al. 2015) . In addition, the last two systematic reviews have come to conclusions, that restrictive vs. liberal SpO2 had no significant effect on the primary composite outcome of death or major disability or on the major disability alone (Askie et al. 2017 , Manja et al. 2017 ).
Interim concluding remarks
Currently, two concepts of the optimal SpO2 target range -narrow (90-94%) and wider (88-94%) are being discussed. However, each carries the risk of either hypoxic or hyperoxic overlaps and is thus unacceptable (Sola et al. 2014; Sweet et al. 2017) . Despite all efforts, considerable uncertainty persists about the desired target range of SpO2 in EPNs'. Further studies should focus on studying newer methods of assessing oxygenation strategies to limit hypoxemia (< 85% SpO2) and hyperoxemia ( > 95% SpO2). The latest reports on clinical experience with automated closed-loop of FiO2 control of oxygen saturation look promising (van Zanten et al. 2017; van den Heuvel et al. 2018) . Kamlin et al. 2006 , Dawson et al. 2010 , Nuntnarumit et al. 2010 ) Table 2 Some of frequently discussed recommendations to the oxygen therapy of very and extremely preterm newborns.
1) Stabilization after delivery:
• Start with FiO2 0.21 -0.3;
• Later -titrate FiO2 according to the clinical status and actual SaO2/SpO2 values.
2) Frequently discussed target ranges of SpO2:
• Higher and narrower target range of 91-94%;
• Lower and wider target range 88-94% [B2].
3) The wider range of SpO2 -easier maintain SpO2 values within desired range and prevent exceeding of alarm stings [C2];
• Setting alarm limits: -lower between 85-87%, upper between 94-96% [D2].
4) Repeatedly exceeded SpO2 target limits indicate examination of the PaO2 and SaO2 from arterial blood sample.
5) Hemoglobin (Hb) concentrations in extremely premature neonates with respiratory support and oxygen when considering transfusion of erythrocytes:
• during the 1st week of birth: Hb 115 g/l (Hct 0.35);
• until 2 weeks after delivery: Hb 110 g/l (Hct 0.30);
• after the 2 nd week of delivery: Hb 85 g/l (Hct 0.25) [C2].
Grading according to the GRADE system (Guyatt HG et al., 2011) 
